All Articles

Beyond a simple conference, Tsingke Biotech's recent salon was a strategic play to position itself as the linchpin in China's shift to biotech innovation.

Mitlin Financial's Lawrence Sprung is a finalist for two prestigious 'Wealthies' awards. His secret? A 'JOY-driven' philosophy that's challenging the industry.

ManageEngine launches its developer Marketplace, entering a field dominated by giants. Can its 'symbiotic' model and strict security governance set it apart?

The tech firm's new funding addresses urgent debt amid Nasdaq delisting threats, revealing a complex financial maneuver to keep its K-culture dreams alive.

A $23 pocket device claims to kill bug bite itch with heat. We go beyond the hype to analyze the science, the market, and the real-world trade-off.

A state-of-the-art cinema is for sale. More than a transaction, it’s a referendum on the future of suburban town centers and their anchor tenants.

With a fresh $30M from a long-term investor, Mitesco is shedding its past to chase high-growth acquisitions in the booming data center and AI sectors.

Ludeo's new platform turns videos into playable demos, promising a massive conversion boost for developers struggling to be seen in a crowded market.

GEDCO's recent fundraiser reveals a strategic shift, where corporate capital is no longer just charity but a vital investment in community stability.

GoNetspeed's $43M expansion isn't just about faster internet for four NJ towns. It's a challenge to incumbents and a look into our connected future.

With identity attacks soaring, Huntress's new managed service claims it can prevent most incidents. We dig into the data behind the bold claims.

The race to recycle EV batteries is creating a $31.8 billion market. We explore the tech, the players, and the investments driving this green gold rush.

NVIDIA’s DGX Spark puts a petaflop of AI power on every desk. Now, Progress Chef is delivering the enterprise-grade control needed to manage this revolution.

A new collaboration between AustinPx and Thermo Fisher is scaling up KinetiSol, a breakthrough tech that makes insoluble drugs viable, promising greener paths to new therapies.

A landmark report challenges the doomsday narrative around Google's AI Overviews, revealing that brands measuring true impact, not just clicks, saw revenues climb.

A landmark partnership between procurement giant Avendra and tech innovator Folio is unlocking savings for hotels by making compliance the path of least resistance.

Insurance giant Travelers built its own LLM, outperforming commercial models. This isn't just a tech upgrade; it's a strategic move reshaping risk.

Digi International's new AI, DANI, isn't just another layer. It's a native agent in its DRM platform, using conversational AI to transform network ops.

Millions suffer from chronic cough with no cure. A Boston biotech is testing a novel aerosol that targets the root cause, not just symptoms. Could it be the first disease-modifying treatment?